- Clinical Trials
- April 2024
- 210 Pages
Global
From €2417EUR$2,500USD£2,076GBP
- Drug Pipelines
- April 2024
- 40 Pages
Global
From €1208EUR$1,250USD£1,038GBP
- Report
- April 2024
- 273 Pages
Global
From €5269EUR$5,450USD£4,526GBP
- Report
- January 2022
- 60 Pages
Global
From €3819EUR$3,950USD£3,280GBP
- Report
- January 2022
- 60 Pages
Global
From €3819EUR$3,950USD£3,280GBP
- Report
- January 2022
- 200 Pages
Global
From €7251EUR$7,500USD£6,228GBP
- Report
- January 2022
- 200 Pages
Global
From €7251EUR$7,500USD£6,228GBP
- Report
- August 2022
United States
From €1876EUR$1,940USD£1,611GBP
- Report
- August 2021
Global
From €3857EUR$3,990USD£3,313GBP
- Report
- August 2021
Europe
From €3306EUR$3,420USD£2,840GBP
- Report
- August 2022
Global
From €957EUR$990USD£822GBP
- Report
- February 2021
Global
From €2862EUR$2,960USD£2,458GBP
- Report
- August 2020
- 48 Pages
Global
From €3862EUR$3,995USD£3,318GBP
- Drug Pipelines
- November 2020
- 358 Pages
Global
From €1934EUR$2,000USD£1,661GBP
- Drug Pipelines
- September 2020
- 57 Pages
Global
From €1934EUR$2,000USD£1,661GBP
- Report
- March 2022
- 157 Pages
Global
From €3480EUR$3,600USD£2,990GBP
- Report
- March 2022
- 71 Pages
Middle East, Africa
From €1450EUR$1,500USD£1,246GBP
- Report
- March 2022
- 71 Pages
Asia Pacific
From €1450EUR$1,500USD£1,246GBP
- Report
- March 2022
- 64 Pages
North America
From €1450EUR$1,500USD£1,246GBP
- Report
- August 2023
- 96 Pages
Global
From €3500EUR$3,878USD£3,112GBP
The Retinopathy Drug market is a subset of the Optical Disorders Drugs market, which includes drugs used to treat diseases of the eye. Retinopathy drugs are used to treat diseases of the retina, such as age-related macular degeneration, diabetic retinopathy, and retinitis pigmentosa. These drugs can be administered orally, topically, or by injection. Commonly used retinopathy drugs include anti-VEGF agents, corticosteroids, and photodynamic therapy.
The Retinopathy Drug market is highly competitive, with many companies developing and marketing drugs to treat retinopathy. Some of the major players in the market include Regeneron Pharmaceuticals, Novartis, Allergan, Roche, and Bayer. Show Less Read more